Intracoronary abciximab in STEMI using local drug delivery catheter – Single center experience
Indian Heart Journal, 2013 Background: Despite restoration of epicardial flow during primary PCI in STEMI, microvascular obstruction may persist as a result of both atheromatous and thrombotic embolization and vasospasm.
G. Sengottuvelu, V. Ravi Sekar
doaj +2 more sources
Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction [PDF]
New England Journal of Medicine, 2002 Gregg W. Stone +11 more
exaly +2 more sources
Breaking the Barrier: Unraveling the No-Reflow Phenomenon in Cardiovascular Medicine. [PDF]
Catheter Cardiovasc IntervABSTRACT The no‐reflow phenomenon is a stubborn and often devastating complication in cardiovascular medicine, where blood flow is restored to an artery, yet the microvasculature remains unresponsive. First identified in 1967, this phenomenon has haunted clinicians and researchers alike, particularly in the context of acute myocardial infarction (AMI).
Howes S +9 more
europepmc +2 more sources
Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper. [PDF]
AllergyABSTRACT Antiplatelet drug (APD) therapy is the cornerstone for the prevention of atherosclerotic cardiovascular disease. The main APDs are aspirin and thienopyridines, particularly clopidogrel. These drugs may induce hypersensitivity reactions (HSRs).
Cortellini G +10 more
europepmc +2 more sources
Modeling Versus Balancing Approaches to Addressing Instrumental Variables in Weighting: A Comparison of the Outcome-Adaptive Lasso, Stable Balancing Weighting, and Stable Confounder Selection. [PDF]
Pharmacoepidemiol Drug SafABSTRACT Background Variable selection is essential for propensity score (PS)‐weighted estimators. Recent work shows that including instrumental variables (IVs), associated with only treatment but not with the outcome, can impact both the bias and precision of the PS‐weighted estimators.
Choi BY, Brookhart MA.
europepmc +2 more sources
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up [PDF]
European Heart Journal, 2007 David Antoniucci +2 more
exaly +2 more sources
Development of Reference Intervals for the TEG 6s, a Point-of-Care Viscoelastic Assay, in Dogs. [PDF]
Vet Clin PatholABSTRACT Background Thromboelastography (TEG) provides a global assessment of hemostasis and identifies patients with both hemorrhagic and thrombotic tendencies. Traditional TEG instruments, such as the TEG 5000 (Haemonetics), can be labor‐intensive and require specialized training to operate.
Wilkinson AR, Conner BJ, Serpa PBS.
europepmc +2 more sources
Sustainable Practices in Anti-VEGF Therapy: A 15-Year Bibliometric Analysis of Ranibizumab for Age-Related Macular Degeneration. [PDF]
J OphthalmolObjective: A bibliometric analysis was performed in the domain of ranibizumab and age‐related macular degeneration (AMD) to delineate current trends in international research dynamics and to provide a visual representation of research hotspots and challenges associated with ophthalmic drugs over the past 15 years.
Xiaodong L +5 more
europepmc +2 more sources
A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with Clopidogrel [PDF]
New England Journal of Medicine, 2004 Adnan Kastrati, Peter B Berger
exaly +2 more sources
Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research. [PDF]
, 2017 Acute ischemic stroke is a devastating cause of death and disability, consequences of which depend on the time from ischemia onset to treatment, the affected brain region, and its size.
Akyol, Onat +6 more
core +8 more sources